Tirzepatide is a synthetic 39-amino-acid peptide that activates both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. This dual “twincretin” mechanism is why it is one of the most requested metabolic research compounds of 2026
$40.00